Caribou Biosciences, Inc. (CRBU)

Import this data to Google Sheets with:

=jivedata("CRBU","financials")

Full statements spill as a table. For one cell: =jivedata("CRBU","Revenue") or =jivedata("CRBU","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Caribou Biosciences, Inc.

CRBU • CIK 0001619856

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$34,477	$9,994	$11,159	$10,035
Operating Income (Loss)	$-116,059	$-166,616	$-148,344	$-109,472
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-101,877	$-149,114	$-148,675	$-148,675
Income Tax Expense (Benefit)	$193	$-9	$-550	$-550
Net Income (Loss) Attributable to Parent	$-102,070	$-149,105	$-148,125	$-103,403
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-100,522	$-148,880	$-148,277	$-103,514
Weighted Average Number of Shares Outstanding, Basic	73,807,597	90,317,925	93,389,283	98,972,085
Research and Development Expense	$112,075	$130,153	$109,439	$85,769
General and Administrative Expense	$38,461	$46,457	$37,914	$33,738
Asset Impairment Charges	—	—	$12,150	$0
Operating Expenses	$150,536	$176,610	$159,503	$119,507
Other Nonoperating Income	$15,476	$15,348	$8,827	$6,304
Nonoperating Income (Expense)	$14,182	$17,502	$-331	$5,519
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax	$1,548	$225	$-152	$-111

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$51,162	$16,293	$12,360	$26,194
Debt Securities, Available-for-sale, Current	$277,665	$193,244	$126,980	$86,120
Accounts Receivable, after Allowance for Credit Loss, Current	$148	$265	$69	$203
Assets	$432,209	$313,313	$175,367	$142,774
Contract with Customer, Asset, after Allowance for Credit Loss, Current	$1,425	$1,158	$1,006	$603
Other Receivables	$2,286	$1,828	$1,904	$1,445
Prepaid Expense and Other Assets, Current	$6,155	$6,589	$2,913	$2,340
Assets, Current	$338,841	$219,377	$145,232	$116,595
Equity Method Investments	$7,753	$9,276	$0	$0
Debt Securities, Available-for-sale, Noncurrent	$43,577	$39,849	$3,505	$1,504
Property, Plant and Equipment, Net	$18,270	$19,281	$6,760	$5,499
Liabilities	$63,808	$60,362	$53,192	$44,672
Operating Lease, Right-of-Use Asset	$22,182	$20,009	$17,670	$17,035
Other Assets, Noncurrent	$1,586	$5,521	$2,200	$2,141
Accounts Payable, Current	$3,120	$2,476	$5,783	$3,080
Accrued Liabilities, Current	$21,135	$23,620	$16,535	$13,145
Operating Lease, Liability, Current	$1,200	$1,426	$1,201	$1,377
Contract with Customer, Liability, Current	$2,847	$3,129	$1,895	$372
Liabilities, Current	$28,302	$30,651	$25,414	$17,974
Contract with Customer, Liability, Noncurrent	$6,102	$3,317	$1,752	$1,420
Operating Lease, Liability, Noncurrent	$25,908	$25,061	$26,026	$25,278
Deferred Income Tax Liabilities, Net	$557	$548	$0	$0
Common Stock, Value, Issued	$8	$9	$9	$11
Additional Paid in Capital	$667,648	$701,077	$718,578	$744,044
Accumulated Other Comprehensive Income (Loss), Net of Tax	$30	$255	$103	$-71
Retained Earnings (Accumulated Deficit)	$-299,285	$-448,390	$-596,515	$-645,882
Stockholders' Equity Attributable to Parent	$368,401	$252,951	$122,175	$98,102
Common Stock, Shares Authorized	300,000,000	300,000,000	300,000,000	300,000,000
Common Stock, Shares, Issued	88,448,948	92,378,577	95,143,690	105,995,653
Property, Plant and Equipment, Gross	$27,414	$32,166	$20,287	$20,300
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$9,144	$12,885	$13,527	$14,801
Accumulated Depreciation, Depletion and Amortization, Reclassifications from Property, Plant and Equipment	$3,500	$3,900	$3,600	$1,300
Employee-related Liabilities, Current	$9,517	$8,560	$6,109	$5,378
Other Liabilities, Current	$1,106	$1,661	$816	$1,699

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-102,070	$-149,105	$-148,125	$-103,403
Net Cash Provided by (Used in) Operating Activities	$-93,291	$-138,200	$-110,992	$-95,780
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-7,176	$-34,869	$-3,933	$947
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$51,208	$16,339	$12,406	$-4,954
Depreciation, Depletion and Amortization	$3,525	$3,927	$3,645	$2,587
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	$338,188	$397,492	$252,830	$215,789
Gain (Loss) on Disposition of Assets	$34	$9	$25	$0
Payments to Acquire Marketable Securities	$394,758	$304,393	$149,233	$144,069
Asset Impairment Charges	—	—	$12,150	$0
Payments to Acquire Property, Plant, and Equipment	$11,613	$4,880	$1,359	$-28
Proceeds from Sale of Property, Plant, and Equipment	—	$13	$0	$0
Payments to Acquire in Process Research and Development	$0	$1,625	$0	$0
Equity Securities, FV-NI, Gain (Loss)	$-6	$-111	$-99	$-103
Net Cash Provided by (Used in) Investing Activities	$-68,183	$86,607	$102,238	$71,748
Share-based Payment Arrangement, Noncash Expense	$13,750	$16,706	$12,680	$10,503
Accretion (Amortization) of Discounts and Premiums, Investments	$4,425	$4,726	$1,140	$708
Increase (Decrease) in Accounts Receivable	$-54	$117	$-196	$132
Proceeds from Issuance of Private Placement	$17,290	$0	—	$0
Increase (Decrease) in Contract with Customer, Asset	$-822	$-267	$-152	$-150
Increase (Decrease) in Other Receivables	$71	$-458	$76	$-822
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised	—	$914	$745	$745
Increase (Decrease) in Prepaid Expense and Other Assets	$-1,766	$433	$-3,675	$-3,438
Proceeds from Issuance of Common Stock	$1,007	$15,192	$4,070	$24,213
Increase (Decrease) in Other Operating Assets	$48	$3,935	$-3,350	$-1,467
Net Cash Provided by (Used in) Financing Activities	$154,298	$16,724	$4,821	$24,979
Increase (Decrease) in Accounts Payable	$1,819	$-354	$3,254	$-163
Increase (Decrease) in Accrued Liabilities	$5,743	$2,134	$-6,340	$-7,317
Increase (Decrease) in Contract with Customer, Liability	$-16,943	$-2,503	$-2,798	$-2,808
IncreaseDecreaseInOperatingLeaseLiability	$-637	$-621	$-1,349	$-1,286
Increase (Decrease) in Deferred Liabilities	$177	$-10	$-548	$-548
Cash and Cash Equivalents, at Carrying Value	$51,162	$16,293	$12,360	$-5,000
Restricted Cash and Cash Equivalents, Current	$46	$46	$46	$46
Capital Expenditures Incurred but Not yet Paid	$692	$754	$60	$-7
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$0	—	$2,089	$2,089

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("CRBU","financials")

Full statements spill as a table. For one cell: =jivedata("CRBU","Revenue") or =jivedata("CRBU","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.